A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Clinical trial NCT07113522 · RECRUITING

Trial details

NCT number: NCT07113522
Sponsor: Mirador Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Inflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)Crohn's Disease

Start date: 2025-06-26
Primary completion: 2027-04-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.